Vitamin supplements in Japan. (Photographer: Tomohiro Ohsumi/Bloomberg)

Which Is The Best Pharma Stock?#AskBQ

#AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment choice in the equity market.

In today’s episode, Gaurang Shah of Geojit Financial Services and Abhijit Phatak of Definedge Solutions, share their views on Tata Motors, LT Foods, Bandhan Bank, and Aurobindo Pharma, among others.

Watch the full conversation here:

Here are the edited excerpts from the conversation:

Subash: Can I make a fresh entry in LT Foods?

Gaurang Shah: I don’t cover the stock. Agro stocks, in general, succumb under pressure due to government policies. Look at auto stocks like Ashok Leyland. Financial sector stocks Federal Bank and L&T Financial Holdings look better.

Manohar: In which stocks should I invest in to buy a bike in one year? I already hold shares of NCC and NBCC at average prices of Rs 99 and Rs 78, respectively.

Shah: Next one year is difficult to make decent returns in equity market as state elections and general elections are lining up. If time horizon is extended to 18-24 months; NBCC will take a longer time for return. Stocks like NCC, L&T Financial Holdings, Ashok Leyland and Federal Bank look attractive in the long run.

Yash: I have bought 100 shares of Tata Motors at Rs 260 levels. What is your long-term view?

Shah: We are optimistic on Tata Motors. We have set a target of around Rs 445 for 2.5-3 years time horizon.

Rangarajan Balakrishnan: What is your view on Bandhan Bank for 90 days?

Abhijit Phatak: It has been consolidating. It can reach Rs 700-750 levels as long as it doesn’t go below Rs 600-610 levels.

Girish Patil: Which pharma stock should I invest in? And, what should my broad duration?

Shah: Negative news of one stock drags the whole sector down. However, it has been benefiting from a falling rupee. Aurobindo Pharma, Glenmark, Lupin, Cipla and Natco are some of the investment ideas.

Viewer: I have bought Torrent Power at Rs 268. What is your view for the next three months?

Phatak: It has to close above Rs 275-278 levels. If that mark is reached, it can go towards Rs 300. The investor can hold it with a stop-loss of Rs 240.

Analyst disclosures: Both analysts don’t hold any stock that were discussed today.

Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.

Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.

BloombergQuint’s digital and social media platforms provide views of only SEBI-registered investment advisors/analysts.